Evidence map›Paper›PMID 18362103›Full record

ArticleMolecular pharmacology2008

A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells.

Aurélia Ravni, David Vaudry, Matthew J Gerdin, Maribeth V Eiden, Anthony Falluel-Morel, Bruno J Gonzalez, Hubert Vaudry, Lee E Eiden

Abstract readComparative Study
In one paragraph

Article in Molecular pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 91 citations in OpenAlex.

  1. PACAP versus CGRP in migraine: From mouse models to clinical translation.Cephalalgia : an international journal of headache · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Neurite Outgrowth-Promoting Compounds from the Petals ofMolecules (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Genus Ziziphus for the treatment of chronic inflammatory diseases.Saudi journal of biological sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Aurélia RavniSection on Molecular Neuroscience, National Institute of Mental Health, Bethesda, MD 20892, USA.
David Vaudry
Matthew J Gerdin
Maribeth V Eiden
Anthony Falluel-Morel
Bruno J Gonzalez
Hubert Vaudry
Lee E Eiden
National Institute of Mental Health · US

Funding

Chemical Coding Of NeurotransmissionZIAMH002386 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI EIDEN, LEE E. · 2009 to 2025
$25.6M
Viral And Cellular Factors Governing Efficient Gene DeliveryZIAMH002592 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI EIDEN, MARIBETH V. · 2009 to 2015
$7.9M
NEUROSECRETORY VESICLED PROTEINS AND CHEMICAL CODING OF NEUROTRANSMISSIONZ01MH002386 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI EIDEN, LEE E. · 1987 to 2008
$3.6M
Intramural NIH HHS Z01 MH002386Intramural NIH HHS ZIA MH002386
6 · The paper itself

Abstract

The neurotrophic peptide PACAP (pituitary adenylate cyclase-activating polypeptide) elevates cAMP in PC12 cells. Forskolin and dibutyryl cAMP mimic PACAP's neuritogenic and cell morphological effects, suggesting that they are driven by cAMP. Comparison of microarray expression profiles after exposure of PC12 cells to either forskolin, dibutyryl cAMP, or PACAP revealed a small group of cAMP-dependent target genes. Neuritogenesis induced by all three agents is protein kinase A (PKA)-independent [not blocked by N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89)] and extracellular signal-regulated kinase (ERK)-dependent [blocked by 1,4-diamino-2,3-dicyano-1,4-bis(methylthio) butadiene (U0126)], and therefore cAMP-dependent target genes potentially mediating neuritogenesis were selected for further analysis based on the pharmacological profile of their induction by PACAP (i.e., mimicking that of neuritogenesis). Small interfering RNA (siRNA) targeting one of these genes, Egr1, blocked PACAP-induced neuritogenesis, and siRNA targeting another, Vil2, blocked a component of the cell size increase elicited by PACAP. Neither siRNA blocked PACAP's PKA-dependent antiproliferative effects. PACAP signaling to neuritogenesis was also impaired by dominant-negative Rap1 expression but was not affected by inhibition of protein kinase C (PKC), indicating a G-protein-coupled receptor-mediated differentiation pathway distinct from the one activated by receptor tyrosine kinase ligands such as nerve growth factor (NGF), that involves both Rap1 and PKC. We have thus identified a cAMP-dependent, PKA-independent pathway proceeding through ERK that functions to up-regulate the transcription of two genes, Egr1 and Vil2, required for PACAP-dependent neuritogenesis and increased cell size, respectively. Dominant-negative Rap1 expression impairs both PACAP-induced neuritogenesis and Egr1 activation by PACAP, suggesting that cAMP elevation and ERK activation by PACAP are linked through Rap1.

Indexed as

AnimalsCyclic AMP-Dependent Protein KinasesEarly Growth Response Protein 1NeuritesPC12 CellsPituitary Adenylate Cyclase-Activating PolypeptideRatsSignal TransductionCyclic AMP-Dependent Protein KinasesEarly Growth Response Protein 1Egr1 protein, ratPituitary Adenylate Cyclase-Activating Polypeptide

Identifiers

PMID18362103
PMCPMC4188547
OpenAlexW2144189667

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.